Thank you Yoda. You are correct. The SaaS offering IS the main product and is sold on less radiation exposure and no additional equipment costs. I very much doubt that something that only looked at existing results the same way would be making the size of splash that this is.The SaaS here uses existing equipment and interprets the outputs differently, it does not just analyse existing scans differently.
IPO - 4DMedical Limited, page-53
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $184.7M | |||
| Open | High | Low | Value | Volume |
| 45.5¢ | 45.5¢ | 44.0¢ | $41.62K | 93.22K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4600 | 45.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.0¢ | 7534 | 2 |
View Market Depth
| Last trade - 10.05am 16/08/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |